PMID- 29075536 OWN - NLM STAT- MEDLINE DCOM- 20180622 LR - 20181113 IS - 1687-5443 (Electronic) IS - 2090-5904 (Print) IS - 1687-5443 (Linking) VI - 2017 DP - 2017 TI - Neural Plasticity Associated with Hippocampal PKA-CREB and NMDA Signaling Is Involved in the Antidepressant Effect of Repeated Low Dose of Yueju Pill on Chronic Mouse Model of Learned Helplessness. PG - 9160515 LID - 10.1155/2017/9160515 [doi] LID - 9160515 AB - Yueju pill is a traditional Chinese medicine formulated to treat syndromes of mood disorders. Here, we investigated the therapeutic effect of repeated low dose of Yueju in the animal model mimicking clinical long-term depression condition and the role of neural plasticity associated with PKA- (protein kinase A-) CREB (cAMP response element binding protein) and NMDA (N-methyl-D-aspartate) signaling. We showed that a single low dose of Yueju demonstrated antidepressant effects in tests of tail suspension, forced swim, and novelty-suppressed feeding. A chronic learned helplessness (LH) protocol resulted in a long-term depressive-like condition. Repeated administration of Yueju following chronic LH remarkably alleviated all of depressive-like symptoms measured, whereas conventional antidepressant fluoxetine only showed a minor improvement. In the hippocampus, Yueju and fluoxetine both normalized brain-derived neurotrophic factor (BDNF) and PKA level. Only Yueju, not fluoxetine, rescued the deficits in CREB signaling. The chronic LH upregulated the expression of NMDA receptor subunits NR1, NR2A, and NR2B, which were all attenuated by Yueju. Furthermore, intracerebraventricular administration of NMDA blunted the antidepressant effect of Yueju. These findings supported the antidepressant efficacy of repeated routine low dose of Yueju in a long-term depression model and the critical role of CREB and NMDA signaling. FAU - Zou, Zhilu AU - Zou Z AD - Center for Translational Systems Biology and Neuroscience and Key Laboratory of Integrative Biomedicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing 210023, China. FAU - Chen, Yin AU - Chen Y AD - Center for Translational Systems Biology and Neuroscience and Key Laboratory of Integrative Biomedicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing 210023, China. FAU - Shen, Qinqin AU - Shen Q AD - Center for Translational Systems Biology and Neuroscience and Key Laboratory of Integrative Biomedicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing 210023, China. FAU - Guo, Xiaoyan AU - Guo X AD - Center for Translational Systems Biology and Neuroscience and Key Laboratory of Integrative Biomedicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing 210023, China. FAU - Zhang, Yuxuan AU - Zhang Y AD - Center for Translational Systems Biology and Neuroscience and Key Laboratory of Integrative Biomedicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing 210023, China. FAU - Chen, Gang AU - Chen G AUID- ORCID: 0000-0002-3894-6294 AD - Center for Translational Systems Biology and Neuroscience and Key Laboratory of Integrative Biomedicine for Brain Diseases, Nanjing University of Chinese Medicine, Nanjing 210023, China. LA - eng PT - Journal Article DEP - 20170917 PL - United States TA - Neural Plast JT - Neural plasticity JID - 100883417 RN - 0 (Antidepressive Agents) RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - 0 (Drugs, Chinese Herbal) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 0 (Yueju-Wan) RN - EC 2.7.11.11 (Cyclic AMP-Dependent Protein Kinases) SB - IM MH - Animals MH - Antidepressive Agents/*pharmacology/therapeutic use MH - Cyclic AMP Response Element-Binding Protein/*metabolism MH - Cyclic AMP-Dependent Protein Kinases/*metabolism MH - Depression/drug therapy/metabolism MH - Disease Models, Animal MH - Drugs, Chinese Herbal/*pharmacology/therapeutic use MH - Female MH - *Helplessness, Learned MH - Male MH - Mice MH - Neuronal Plasticity/*drug effects/physiology MH - Receptors, N-Methyl-D-Aspartate/*metabolism MH - Signal Transduction/*drug effects MH - Treatment Outcome MH - Up-Regulation/drug effects PMC - PMC5623799 EDAT- 2017/10/28 06:00 MHDA- 2018/06/23 06:00 PMCR- 2017/09/17 CRDT- 2017/10/28 06:00 PHST- 2017/04/15 00:00 [received] PHST- 2017/07/16 00:00 [revised] PHST- 2017/08/03 00:00 [accepted] PHST- 2017/10/28 06:00 [entrez] PHST- 2017/10/28 06:00 [pubmed] PHST- 2018/06/23 06:00 [medline] PHST- 2017/09/17 00:00 [pmc-release] AID - 10.1155/2017/9160515 [doi] PST - ppublish SO - Neural Plast. 2017;2017:9160515. doi: 10.1155/2017/9160515. Epub 2017 Sep 17.